Intrathecal injection of ketamine and Clonidine for chronic neuropathic pain model in rats

Zheng-Hua He,Qu-Lian Guo,Wang-Yuan Zou,Chang-Sheng Huang

DOI: https://doi.org/10.3321/j.issn:1672-7347.2007.04.034

2007-01-01

Abstract:Objective To observe the effect of intrathecal injection of ketamine and Clonidine for chronic constriction injury (CCl) in rats. Methods Thirty-two SD male rats weighing 220- 280 g were anesthetized with intraperitoneal chloral hydrate 300 mg/kg. A catheter was implanted in the subarachnoid space at the lumbal region and CCI rat models were made successfully. On the 4th day after the surgery, the rats were randomly divided into 4 group : a control group , injecting 0.9% NS 20 μL intrathecally; a ketamine group, injecting ketamine 1 mg/kg (20 μL ) intrathecally; a Clonidine group (CL), injecting Clonidine 20 μg/kg (20 μL) intrathecally; a combined ketamine and Clonidine group, injecting ketamine 0.5 mg/kg and Clonidine 10 g/kg (20 μL) intrathecally, once a day for 1 week. BME -410 A Plantar Analgesia Tester was used to measured pain threshold before the adminstration and 30 min after the adminstration. The rats were killed after the test was finished. And then we detected the nitric oxide synthase (NOS) activity and the NO production in the spinal cord. Results The combined injection of ketamine (0.5 mg/kg) and Clonidine (10 g/ kg ) produced significantly more potent analgesia than the injection of ketamine (1 mg/ kg ) or Clonidine (20 (μg/ kg) alone. The NOS activity and the production of NO in the combined injection group were significantly lower than those of the single injection group (P < 0. 05). The weight of rats post-adminstration increased obviously in the 4 groups ( P < 0. 05). Conclusion The combined injection of ketamine and Clonidine can produce synergistic abirritation without obvious side effects.